News

With a new hydrogel material, researchers have developed a hormone-free treatment that alleviates the vaginal dryness and pain caused by genitourinary syndrome of menopause (GSM), which negatively impacts quality of life for millions of women.

Scientists discovered that NAPE, a “three-tailed” fat molecule, helps protect cells during oxygen loss caused by stroke or heart attack. NAPE surges under stress, boosting lactic acid export and preventing toxic buildup.

Scientists found that residual intra-abdominal microbes, especially in frail patients, drive gastrointestinal complications after bladder cancer surgery.

How rapidly gene expression in a single cell changes over time can provide insight into how cells might become more specialized. A new method incorporated spatial information to this measurement to improve understanding of gene expression changes.

Ethologists at Eötvös Loránd University have created the first standardized diagnostic system for ADHD-like symptoms in family dogs. The system identifies issues with inattention, hyperactivity and impulsivity.

UC San Francisco researchers screened 300 industrial dyes to identify those that bind to protein clumps linked to dementias like Alzheimer’s. They found 10 promising candidates, including one that illuminated tau in brain samples.

A new study offers a promising path toward the development of the world’s first broad-spectrum antiviral, which could be deployed against a wide range of deadly viruses, including future pandemic threats.

ETH Zurich researchers found that “exergames” – fitness games combining movement with brain exercises – improved memory, cognition and brain structure in older adults with mild cognitive impairment.

Using computer vision, a branch of artificial intelligence (AI), scientists have developed an improved 3D printer for designing and bioprinting functional tissues.

Some populations with the highest risk for Alzheimer’s disease remain greatly underrepresented in clinical trials. Participants from these high-risk groups are less likely to have elevated amyloid in the brain based on blood levels of p-tau217.